Nanobiomaterials and Nanomedicines for Metabolic Disorders delves into the transformative role of nanotechnology in addressing metabolic disorders. The book begins with an overview of nanoparticle classifications and then explores the synthesis of biomaterials and drug delivery systems. In addition, it explores innovative diagnostic and imaging techniques while presenting cutting-edge therapeutic approaches. Later chapters focus on specific metabolic disorders, such as cardiovascular and lifestyle-related conditions. The book is tailored to researchers, students, and healthcare professionals…mehr
Nanobiomaterials and Nanomedicines for Metabolic Disorders delves into the transformative role of nanotechnology in addressing metabolic disorders. The book begins with an overview of nanoparticle classifications and then explores the synthesis of biomaterials and drug delivery systems. In addition, it explores innovative diagnostic and imaging techniques while presenting cutting-edge therapeutic approaches. Later chapters focus on specific metabolic disorders, such as cardiovascular and lifestyle-related conditions. The book is tailored to researchers, students, and healthcare professionals seeking advanced theranostic approaches to these disorders. By bridging nanotechnology with metabolic pathways, the text offers insights into how targeted nanomedicines can improve therapeutic outcomes.
Section I: Nanomedicines for metabolic disorders: drug delivery 1. Clinical use of inorganic and organic nanoparticles in metabolic syndromes 2. Application of nanomedicines in mitigating oxidative stress 3. Nanomedicines to enhance oral bioavailability for metabolic disorders 4. Nanotechnology for the therapeutic use of biologics to treat metabolic disorders Section II: Nanotechnology in metabolic disorders: diagnosis and therapy 5. Application of quantum dots in metabolic disorders 6. Medical imaging using nanotechnology 7. Nanorobotics: applications in metabolic disorders 8. Nanomaterials for three-dimensional printing in management of metabolic disorders Section III: Nanomedicines for lifestyle metabolic disorders 9. Nanomedicines to alleviate hepatic metabolic disorders 10. Role of nanomedicines in type 2 diabetes 11. Nanomedicines for precise therapy in hyperlipidaemia & obesity Section IV: Nanomedicines for cellular metabolic disorders 12. Application of nanotechnology in lysosomal storage diseases 13. Nanotechnology to target autophagy-mediated metabolic disorders 14. Application of nanomedicines in glycogen storage diseases Section V: Nanomedicines for metabolic cardiovascular diseases 15. Nanotechnology for metabolic vascular diseases 16. Nanomedicines for the management of atherosclerosis
Section I: Nanomedicines for metabolic disorders: drug delivery 1. Clinical use of inorganic and organic nanoparticles in metabolic syndromes 2. Application of nanomedicines in mitigating oxidative stress 3. Nanomedicines to enhance oral bioavailability for metabolic disorders 4. Nanotechnology for the therapeutic use of biologics to treat metabolic disorders Section II: Nanotechnology in metabolic disorders: diagnosis and therapy 5. Application of quantum dots in metabolic disorders 6. Medical imaging using nanotechnology 7. Nanorobotics: applications in metabolic disorders 8. Nanomaterials for three-dimensional printing in management of metabolic disorders Section III: Nanomedicines for lifestyle metabolic disorders 9. Nanomedicines to alleviate hepatic metabolic disorders 10. Role of nanomedicines in type 2 diabetes 11. Nanomedicines for precise therapy in hyperlipidaemia & obesity Section IV: Nanomedicines for cellular metabolic disorders 12. Application of nanotechnology in lysosomal storage diseases 13. Nanotechnology to target autophagy-mediated metabolic disorders 14. Application of nanomedicines in glycogen storage diseases Section V: Nanomedicines for metabolic cardiovascular diseases 15. Nanotechnology for metabolic vascular diseases 16. Nanomedicines for the management of atherosclerosis
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826